Yeh ES - Search Results

1

The Potential for Connexin Hemichannels to Drive Breast Cancer Progression through Regulation of the Inflammatory Response.

Rhett JM, Yeh ES. Rhett JM, et al. Among authors: yeh es. Int J Mol Sci. 2018 Mar 30;19(4):1043. doi: 10.3390/ijms19041043. Int J Mol Sci. 2018. PMID: 29601539 Free PMC article. Review.

2

Targeting connexin 43 with α-connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1.

Grek CL, Rhett JM, Bruce JS, Abt MA, Ghatnekar GS, Yeh ES. Grek CL, et al. Among authors: yeh es. BMC Cancer. 2015 Apr 3;15:296. doi: 10.1186/s12885-015-1229-6. BMC Cancer. 2015. PMID: 25881004 Free PMC article.

3

Connexin 43, breast cancer tumor suppressor: Missed connections?

Grek CL, Rhett JM, Bruce JS, Ghatnekar GS, Yeh ES. Grek CL, et al. Among authors: yeh es. Cancer Lett. 2016 Apr 28;374(1):117-126. doi: 10.1016/j.canlet.2016.02.008. Epub 2016 Feb 13. Cancer Lett. 2016. PMID: 26884256 Review.

4

Hormonally up-regulated neu-associated kinase: A novel target for breast cancer progression.

Zambrano JN, Neely BA, Yeh ES. Zambrano JN, et al. Among authors: yeh es. Pharmacol Res. 2017 May;119:188-194. doi: 10.1016/j.phrs.2017.02.007. Epub 2017 Feb 9. Pharmacol Res. 2017. PMID: 28189783 Free PMC article. Review.

5

Connexin 43 in the development and progression of breast cancer: What's the connection? (Review).

Phillips SL, Williams CB, Zambrano JN, Williams CJ, Yeh ES. Phillips SL, et al. Among authors: yeh es. Int J Oncol. 2017 Oct;51(4):1005-1013. doi: 10.3892/ijo.2017.4114. Epub 2017 Sep 1. Int J Oncol. 2017. PMID: 28902343 Free PMC article. Review.

6

Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer.

Rutkovsky AC, Yeh ES, Guest ST, Findlay VJ, Muise-Helmericks RC, Armeson K, Ethier SP. Rutkovsky AC, et al. Among authors: yeh es. BMC Cancer. 2019 May 23;19(1):491. doi: 10.1186/s12885-019-5667-4. BMC Cancer. 2019. PMID: 31122207 Free PMC article.

7

Core-Fucosylated Tetra-Antennary N-Glycan Containing A Single N-Acetyllactosamine Branch Is Associated with Poor Survival Outcome in Breast Cancer.

Herrera H, Dilday T, Uber A, Scott D, Zambrano JN, Wang M, Angel PM, Mehta AS, Drake RR, Hill EG, Yeh ES. Herrera H, et al. Among authors: yeh es. Int J Mol Sci. 2019 May 23;20(10):2528. doi: 10.3390/ijms20102528. Int J Mol Sci. 2019. PMID: 31126011 Free PMC article.

8

HUNK Phosphorylates Rubicon to Support Autophagy.

Zambrano JN, Eblen ST, Abt M, Rhett JM, Muise-Helmericks R, Yeh ES. Zambrano JN, et al. Among authors: yeh es. Int J Mol Sci. 2019 Nov 19;20(22):5813. doi: 10.3390/ijms20225813. Int J Mol Sci. 2019. PMID: 31752345 Free PMC article.

9

Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors.

Yeh ES, Abt MA, Hill EG. Yeh ES, et al. Breast Cancer Res Treat. 2015 Jan;149(1):91-8. doi: 10.1007/s10549-014-3227-9. Epub 2014 Dec 17. Breast Cancer Res Treat. 2015. PMID: 25515931 Free PMC article.

10

Perspectives on Epidermal Growth Factor Receptor Regulation in Triple-Negative Breast Cancer: Ligand-Mediated Mechanisms of Receptor Regulation and Potential for Clinical Targeting.

Williams CB, Soloff AC, Ethier SP, Yeh ES. Williams CB, et al. Among authors: yeh es. Adv Cancer Res. 2015;127:253-81. doi: 10.1016/bs.acr.2015.04.008. Epub 2015 May 8. Adv Cancer Res. 2015. PMID: 26093903 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters